Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAgilent Technologies Inc

Agilent Technologies Inc

Healthcare Diagnostics & Research
PortfolioPortfolio WatchlistWatchlist
Company price
174.76 USD 2.98 ( 1.73%)
Last update at 2026-11-06T21:00:00Z
VOLUME
1595105
Market Cap
43573.23M
P/E
34.36

Momentum Score

…

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
171.28
Low
176.41
High
52 Week Price Range
123.73
Low
154.53
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Agilent Technologies supplies analytical instruments, consumables, software and services for life sciences, diagnostics and applied chemical markets, supporting pharmaceutical, biotech, environmental and food-testing labs. Long-term growth may be supported by rising R&D and diagnostics spending, adoption of advanced chromatography and mass spectrometry, recurring consumables and service revenue, and expansion in genomics, while the company's diversified end markets and global service footprint appear positioned to sustain stable cash generation.
Material risks include cyclicality of capital-equipment spending, intense competition, supply-chain and execution challenges, and regulatory or reimbursement pressures investors should monitor.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
171.78
Dividend Yield
-
Revenue TTM
6497.00M
Revenue Per Share
22.27
Gross Profit TTM
3465.00M
Debt / Equity
0.57
ROE
24.66%
Net Debt
2061.00M
ROCE
14.41%
Diluted EPS TTM
4.43

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-10-31 2022-10-31 2021-10-31 2020-10-31 2019-10-31
Type yearly yearly yearly yearly yearly
Date 2023-10-31 2022-10-31 2021-10-31 2020-10-31 2019-10-31
Income before tax 1339.00M 1504.00M 1360.00M 842.00M 919.00M
Net income 1240.00M 1254.00M 1210.00M 719.00M 1071.00M
Selling general administrative 1634.00M 1637.00M 1619.00M 1496.00M 1460.00M
Gross profit 3465.00M 3722.00M 3407.00M 2837.00M 2805.00M
Reconciled depreciation 271.00M 317.00M 321.00M 308.00M 238.00M
Ebit 1434.00M 1618.00M 1347.00M 846.00M 941.00M
Ebitda 1705.00M 1905.00M 1762.00M 1228.00M 1231.00M
Depreciation and amortization 271.00M 287.00M 415.00M 382.00M 290.00M
Non operating income net other - -30.00M 94.00M 74.00M 52.00M
Operating income 1350.00M 1618.00M 1347.00M 846.00M 941.00M
Other operating expenses 5483.00M 5230.00M 4972.00M 4493.00M 4222.00M
Interest expense 95.00M 84.00M 81.00M 78.00M 74.00M
Tax provision 99.00M 250.00M 150.00M 123.00M -152.00M
Interest income 51.00M 9.00M 79.00M 70.00M 36.00M
Net interest income -44.00M -75.00M -79.00M -70.00M -38.00M
Income tax expense 99.00M 250.00M 150.00M 123.00M -152.00M
Total revenue 6833.00M 6848.00M 6319.00M 5339.00M 5163.00M
Total operating expenses 2115.00M 2104.00M 2060.00M 1991.00M 1864.00M
Cost of revenue 3368.00M 3126.00M 2912.00M 2502.00M 2358.00M
Total other income expense net 33.00M -114.00M 13.00M -4.00M -22.00M
Net income from continuing ops 1240.00M 1254.00M 1210.00M 719.00M 1071.00M
Net income applicable to common shares - 1254.00M 1210.00M 719.00M 1071.00M
Breakdown 2024-10-31 2023-10-31 2022-10-31 2021-10-31 2020-10-31
Type yearly yearly yearly yearly yearly
Date 2024-10-31 2023-10-31 2022-10-31 2021-10-31 2020-10-31
Total assets 11846.00M 10763.00M 10516.00M 10705.00M 9627.00M
Intangible assets 547.00M 475.00M 821.00M 981.00M 831.00M
Other current assets 334.00M 274.00M 282.00M 222.00M 216.00M
Total liab 5948.00M 4918.00M 5227.00M 5316.00M 4754.00M
Total stockholder equity 5898.00M 5845.00M 5289.00M 5389.00M 4873.00M
Other current liab 1310.00M 680.00M 784.00M 821.00M 652.00M
Common stock 3.00M 3.00M 3.00M 3.00M 3.00M
Capital stock - 3.00M 3.00M 3.00M 3.00M
Retained earnings 750.00M 782.00M 324.00M 348.00M 81.00M
Other liab - - 633.00M 879.00M 876.00M
Good will 4477.00M 3960.00M 4773.00M 4956.00M 4433.00M
Other assets - - 670.00M 820.00M 601.00M
Cash 1329.00M 1590.00M 1053.00M 1484.00M 1441.00M
Cash and equivalents - - 1053.00M 1484.00M 1441.00M
Total current liabilities 1895.00M 1603.00M 1861.00M 1708.00M 1467.00M
Current deferred revenue - 505.00M 461.00M 441.00M 386.00M
Net debt 2061.00M 1145.00M 1716.00M 1245.00M 918.00M
Short term debt 45.00M - 36.00M 0.00M 75.00M
Short long term debt - - 36.00M - 75.00M
Short long term debt total 3390.00M 2735.00M 2769.00M 2729.00M 2359.00M
Other stockholder equity 5450.00M 5387.00M 5325.00M 5320.00M 5311.00M
Property plant equipment - - 1100.00M 945.00M 845.00M
Total current assets 3959.00M 4186.00M 3778.00M 3799.00M 3415.00M
Long term investments - 164.00M 195.00M 185.00M 158.00M
Net tangible assets - - 516.00M 433.00M 440.00M
Short term investments - - 0.00M 91.00M 158.00M
Net receivables 1324.00M 1291.00M 1405.00M 1172.00M 1038.00M
Long term debt - 2735.00M 2733.00M 2729.00M 2284.00M
Inventory 972.00M 1031.00M 1038.00M 830.00M 720.00M
Accounts payable 540.00M 418.00M 580.00M 446.00M 354.00M
Accumulated other comprehensive income -305.00M -327.00M -363.00M -282.00M -522.00M
Common stock total equity - - 3.00M 3.00M 3.00M
Retained earnings total equity - - 324.00M 348.00M 81.00M
Non currrent assets other 910.00M 708.00M 670.00M 820.00M 776.00M
Non current assets total 7887.00M 6577.00M 6738.00M 6906.00M 6212.00M
Long term debt total - - 2733.00M 2729.00M 2284.00M
Breakdown 2023-10-31 2022-10-31 2021-10-31 2020-10-31 2019-10-31
Type yearly yearly yearly yearly yearly
Date 2023-10-31 2022-10-31 2021-10-31 2020-10-31 2019-10-31
Investments -310.00M 9.00M -10.00M -29.00M -26.00M
Change to liabilities - 121.00M 64.00M 31.00M 52.00M
Total cashflows from investing activities - -338.00M -749.00M -147.00M -1590.00M
Net borrowings - 26.00M 356.00M -45.00M 596.00M
Total cash from financing activities -930.00M -1372.00M -696.00M -717.00M -299.00M
Change to operating activities - -30.00M 112.00M -152.00M -26.00M
Net income 1240.00M 1254.00M 1210.00M 719.00M 1071.00M
Change in cash 537.00M -434.00M 43.00M 59.00M -866.00M
Begin period cash flow 1056.00M 1490.00M 1447.00M 1388.00M 2254.00M
End period cash flow 1593.00M 1056.00M 1490.00M 1447.00M 1388.00M
Total cash from operating activities 1772.00M 1312.00M 1485.00M 921.00M 1021.00M
Depreciation 271.00M 317.00M 321.00M 308.00M 238.00M
Other cashflows from investing activities - -4.00M -5.00M 1.00M -1409.00M
Dividends paid -265.00M -250.00M -236.00M -222.00M -206.00M
Change to inventory -33.00M -248.00M -136.00M -68.00M -36.00M
Change to account receivables 132.00M -321.00M -128.00M -107.00M -106.00M
Sale purchase of stock -575.00M -1139.00M -788.00M -469.00M -723.00M
Other cashflows from financing activities -122.00M 1828.00M -83.00M -41.00M -24.00M
Change to netincome - 219.00M 42.00M 247.00M -149.00M
Capital expenditures 298.00M 291.00M 189.00M 119.00M 156.00M
Change receivables - -321.00M -128.00M -107.00M -106.00M
Cash flows other operating - 59.00M -112.00M -209.00M -49.00M
Exchange rate changes - - 3.00M 2.00M 2.00M
Cash and cash equivalents changes - -398.00M 43.00M 59.00M -866.00M
Change in working capital -116.00M -478.00M -88.00M -296.00M -388.00M
Stock based compensation 111.00M 125.00M 110.00M 83.00M 72.00M
Other non cash items 322.00M 86.00M -82.00M 78.00M 283.00M
Free cash flow 1474.00M 1021.00M 1296.00M 802.00M 865.00M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
A
Agilent Technologies Inc		 2.98
1.73%		 174.76 34.36 26.39 6.59 7.14 6.78 23.56
TMO
Thermo Fisher Scientific Inc		 17.82
2.63%		 694.76 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation		 3.91
1.73%		 230.25 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd		 -
-%		 25.45 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd		 -0.31
1.23%		 24.85 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051

800 227 9770

https://www.agilent.com

17400

Name Title Year Born
Mr. Michael R. McMullen CEO, Pres & Director 1961
Mr. Robert W. McMahon Sr. VP & CFO 1969
Mr. Jacob Thaysen Sr. VP and Pres of Life Sciences & Applied Markets Group 1975
Mr. Samraat S. Raha Sr. VP and Pres of Diagnostics & Genomics Group 1973
Mr. Padraig McDonnell Sr. VP & Pres of Agilent Cross Lab Group NA
Mr. Rodney Gonsalves Principal Accounting Officer, VP & Corp. Controller 1966
Dr. Darlene J. S. Solomon Ph.D. CTO & Sr. VP 1959
Mr. Michael Tang Sr. VP, Gen. Counsel & Sec. 1974
Mr. Dominique P. Grau Sr. VP of HR & Global Communications 1959
Ms. Allison Ballmer Sr. VP of Strategy & Corp. Devel. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…